Impact of Trichomonas vaginalis transcription-mediated amplification-based analyte-specific-reagent testing in a metropolitan setting of high sexually transmitted disease prevalence
about
Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay.Female epidemiology of transcription-mediated amplification-based Trichomonas vaginalis detection in a metropolitan setting with a high prevalence of sexually transmitted infectionUnited Kingdom National Guideline on the Management of Trichomonas vaginalis 2014.Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD affirm VPIII for detection of T. vaginalis in symptomatic women: performance parameters and epidemiological implications.Molecular Diagnosis of Sexually Transmitted Chlamydia trachomatis in the United States.Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trialThree-year history of transcription-mediated amplification-based Trichomonas vaginalis analyte-specific reagent testing in a subacute care patient population.Screening of male patients for Trichomonas vaginalis with transcription-mediated amplification in a community with a high prevalence of sexually transmitted infection.Clinical Laboratory Assessment of Mycoplasma genitalium Transcription-Mediated Amplification Using Primary Female Urogenital Specimens.Correlation of leukorrhea and Trichomonas vaginalis infection.Retrospective assessment of transcription-mediated amplification-based screening for Trichomonas vaginalis in male sexually transmitted infection clinic patients.Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans.Diagnosis of Trichomonous vaginalis by microscopy, latex agglutination, diamond's media, and PCR in symptomatic women, Khartoum, Sudan.APTIMA® Trichomonas vaginalis, a transcription-mediated amplification assay for detection of Trichomonas vaginalis in urogenital specimens.Molecular diagnosis of Neisseria gonorrhoeae infection in the United States.Insights into trichomoniasis as a result of highly sensitive molecular diagnostics screening in a high-prevalence sexually transmitted infection community.Clinical laboratory assessments for Mycoplasma genitalium in a high-prevalence sexually-transmitted infection community reveal epidemiologic dichotomies with Trichomonas vaginalis.Suboptimal Trichomonas vaginalis Antigen Test Performance in a Low-Prevalence Sexually Transmitted Infection Community.The Effects of School-Based Discrimination on Adolescents of Color Sexual Health Outcomes: A Social Determinants Approach.
P2860
Q34276878-09CBD481-62A8-496B-AB19-2D6041931332Q34302176-6C4D0997-0DC7-43FA-9A1B-DE7976AB5636Q34409461-22A37057-A52D-4EE9-AEC8-AF3B4DBD3910Q34741096-EE87E982-AD6B-4C4E-B076-5CB10D5DFC4EQ35141880-8F48E8D8-0712-47D3-B0E0-D27A28DEF02AQ35598880-CBAD63D4-0F3F-4503-9E8F-63A5D841CD10Q35598935-242069A2-4CA8-4615-A786-A74983A39A83Q36506408-022FB224-763B-46D9-BEE2-0CD10EDEA379Q36521297-C2041BCE-44AC-487B-8821-222FA80B0ECEQ36970987-924B8291-A21B-4AAE-83AE-22AF47C885DBQ37026400-2F9BC9E1-8CAE-4B0E-AAE0-57ABCDB347C8Q37050952-3F807F26-B5C1-43F8-BE7A-40571D16C0BCQ37684509-683F0AFB-E5BE-4738-BF9C-C7FBEAD8A702Q37929194-D5BB1FF6-3695-4EB9-8E4C-B9B249998494Q38089071-364983DF-164E-4C8A-9850-E3AFC528D246Q38128845-E8078DA2-83FB-4452-9837-A1C3ED10CF0DQ39022306-BA44C87E-1B2E-4EC2-AF67-EC073CE80984Q42537117-B90BF79C-9371-4E25-8C6E-7D52ACC51AB7Q47201803-3C77C75F-835F-4CAD-974D-C93C544AA48C
P2860
Impact of Trichomonas vaginalis transcription-mediated amplification-based analyte-specific-reagent testing in a metropolitan setting of high sexually transmitted disease prevalence
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Impact of Trichomonas vaginali ...... transmitted disease prevalence
@en
type
label
Impact of Trichomonas vaginali ...... transmitted disease prevalence
@en
prefLabel
Impact of Trichomonas vaginali ...... transmitted disease prevalence
@en
P2093
P2860
P921
P356
P1476
Impact of Trichomonas vaginali ...... transmitted disease prevalence
@en
P2093
Erik Munson
Jeanne E Hryciuk
Maureen Napierala
Robin Olson
Ronald F Schell
Timothy Block
Tina Endes
P2860
P304
P356
10.1128/JCM.00564-08
P407
P577
2008-08-27T00:00:00Z